S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

PKS Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive PKS News and Ratings via Email

Sign-up to receive the latest news and ratings for PKS and its competitors with MarketBeat's FREE daily newsletter.

About PKS

PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally. The company offers RippleDown Expert, an CDS system that provides real-time patient monitoring, alerting, data mining, and reporting capability; and RippleDown Auditor, a knowledge based system that allows various departments within a laboratory, including data entry, billing, and specimen reception to audit data in real-time. It also provides LabQ, a data mining tool; PICQ, an auditing tool used in hospital that assesses every record clinically coded for data quality; RISQ to provide industry benchmark of hospital-acquired complications incidence and underlying data quality; and Codexpert, a web-based eBook application providing the full health-data classification reference for clinical coding of patient episodes. The company serves customers through direct sales and channel partners. The company was formerly known as QPro Holdings Limited. PKS Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.


No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Health Information Services
Year Founded

Sales & Book Value

Annual Sales
$5.97 million
Book Value
A$0.16 per share





Next Earnings Date
Not Optionable


Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

PKS (ASX:PKS) Frequently Asked Questions

What stocks does MarketBeat like better than PKS?

Wall Street analysts have given PKS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PKS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are PKS's key executives?

PKS's management team includes the following people:
  • Mr. Paul Richard O'Connor, Exec.
  • Mr. Michael B. Pollitt, Exec.
  • Mr. Tim Kelsey, Chief Exec. Officer
  • Mr. Andrew William Bursill C.A., B.Agr.Ec., CA, Chief Financial Officer (Age 50)
  • Dr. Lindsay Peters, Chief Technical Officer
  • Mr. Michael Reakes, Gen. Mang.
  • Belinda Cleminson, Company Sec.
  • Douglas Henry, Exec.

What is PKS's stock symbol?

PKS trades on the ASX under the ticker symbol "PKS."

How much money does PKS make?

PKS has a market capitalization of $0.00 and generates $5.97 million in revenue each year.

What is PKS's official website?

The official website for PKS is www.pks.com.au.

How can I contact PKS?

The company can be reached via phone at 61 2 8072 1400.

This page was last updated on 10/16/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.